Report Detail
COVID-19 Impact on Global Oncology Based Molecular Diagnostics Market Insights, Forecast to 2026
- RnM3990084 |
- 05 June, 2020 |
- Global |
- 110 Pages |
- QYResearch |
- Medical Devices & Consumables
Oncology Based Molecular Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Based Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oncology Based Molecular Diagnostics market is segmented into
PCR
Multiplex PCR
In Situ Hybridization
Isothermal Nucleic Acid Amplification Technology (INAAT)
Segment by Application, the Oncology Based Molecular Diagnostics market is segmented into
Breast Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Other
Regional and Country-level Analysis
The Oncology Based Molecular Diagnostics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oncology Based Molecular Diagnostics market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Oncology Based Molecular Diagnostics Market Share Analysis
Oncology Based Molecular Diagnostics market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Oncology Based Molecular Diagnostics by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Oncology Based Molecular Diagnostics business, the date to enter into the Oncology Based Molecular Diagnostics market, Oncology Based Molecular Diagnostics product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Bayer Healthcare
Becton Dickinson
Cepheid
Dako
Danaher Corporation
Gen Probe(Hologic)
Roche Diagnostics
1 Study Coverage
- 1.1 Oncology Based Molecular Diagnostics Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Oncology Based Molecular Diagnostics Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Oncology Based Molecular Diagnostics Market Size Growth Rate by Type
- 1.4.2 PCR
- 1.4.3 Multiplex PCR
- 1.4.4 In Situ Hybridization
- 1.4.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 1.5 Market by Application
- 1.5.1 Global Oncology Based Molecular Diagnostics Market Size Growth Rate by Application
- 1.5.2 Breast Cancer
- 1.5.3 Prostate Cancer
- 1.5.4 Colorectal Cancer
- 1.5.5 Cervical Cancer
- 1.5.6 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Oncology Based Molecular Diagnostics Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Oncology Based Molecular Diagnostics Industry
- 1.6.1.1 Oncology Based Molecular Diagnostics Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Oncology Based Molecular Diagnostics Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Oncology Based Molecular Diagnostics Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Oncology Based Molecular Diagnostics Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Oncology Based Molecular Diagnostics Market Size Estimates and Forecasts
- 2.1.1 Global Oncology Based Molecular Diagnostics Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Oncology Based Molecular Diagnostics Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Oncology Based Molecular Diagnostics Production Estimates and Forecasts 2015-2026
- 2.2 Global Oncology Based Molecular Diagnostics Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Oncology Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Oncology Based Molecular Diagnostics Manufacturers Geographical Distribution
- 2.4 Key Trends for Oncology Based Molecular Diagnostics Markets & Products
- 2.5 Primary Interviews with Key Oncology Based Molecular Diagnostics Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Oncology Based Molecular Diagnostics Manufacturers by Production Capacity
- 3.1.1 Global Top Oncology Based Molecular Diagnostics Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Oncology Based Molecular Diagnostics Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Oncology Based Molecular Diagnostics Manufacturers Market Share by Production
- 3.2 Global Top Oncology Based Molecular Diagnostics Manufacturers by Revenue
- 3.2.1 Global Top Oncology Based Molecular Diagnostics Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Oncology Based Molecular Diagnostics Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Oncology Based Molecular Diagnostics Revenue in 2019
- 3.3 Global Oncology Based Molecular Diagnostics Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Oncology Based Molecular Diagnostics Production by Regions
- 4.1 Global Oncology Based Molecular Diagnostics Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Oncology Based Molecular Diagnostics Regions by Production (2015-2020)
- 4.1.2 Global Top Oncology Based Molecular Diagnostics Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Oncology Based Molecular Diagnostics Production (2015-2020)
- 4.2.2 North America Oncology Based Molecular Diagnostics Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Oncology Based Molecular Diagnostics Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Oncology Based Molecular Diagnostics Production (2015-2020)
- 4.3.2 Europe Oncology Based Molecular Diagnostics Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Oncology Based Molecular Diagnostics Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Oncology Based Molecular Diagnostics Production (2015-2020)
- 4.4.2 China Oncology Based Molecular Diagnostics Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Oncology Based Molecular Diagnostics Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Oncology Based Molecular Diagnostics Production (2015-2020)
- 4.5.2 Japan Oncology Based Molecular Diagnostics Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Oncology Based Molecular Diagnostics Import & Export (2015-2020)
5 Oncology Based Molecular Diagnostics Consumption by Region
- 5.1 Global Top Oncology Based Molecular Diagnostics Regions by Consumption
- 5.1.1 Global Top Oncology Based Molecular Diagnostics Regions by Consumption (2015-2020)
- 5.1.2 Global Top Oncology Based Molecular Diagnostics Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Oncology Based Molecular Diagnostics Consumption by Application
- 5.2.2 North America Oncology Based Molecular Diagnostics Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Oncology Based Molecular Diagnostics Consumption by Application
- 5.3.2 Europe Oncology Based Molecular Diagnostics Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Oncology Based Molecular Diagnostics Consumption by Application
- 5.4.2 Asia Pacific Oncology Based Molecular Diagnostics Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Oncology Based Molecular Diagnostics Consumption by Application
- 5.5.2 Central & South America Oncology Based Molecular Diagnostics Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Oncology Based Molecular Diagnostics Consumption by Application
- 5.6.2 Middle East and Africa Oncology Based Molecular Diagnostics Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Oncology Based Molecular Diagnostics Market Size by Type (2015-2020)
- 6.1.1 Global Oncology Based Molecular Diagnostics Production by Type (2015-2020)
- 6.1.2 Global Oncology Based Molecular Diagnostics Revenue by Type (2015-2020)
- 6.1.3 Oncology Based Molecular Diagnostics Price by Type (2015-2020)
- 6.2 Global Oncology Based Molecular Diagnostics Market Forecast by Type (2021-2026)
- 6.2.1 Global Oncology Based Molecular Diagnostics Production Forecast by Type (2021-2026)
- 6.2.2 Global Oncology Based Molecular Diagnostics Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Oncology Based Molecular Diagnostics Price Forecast by Type (2021-2026)
- 6.3 Global Oncology Based Molecular Diagnostics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Oncology Based Molecular Diagnostics Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Oncology Based Molecular Diagnostics Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Corporation Information
- 8.1.2 Abbott Laboratories Overview and Its Total Revenue
- 8.1.3 Abbott Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 Abbott Laboratories Product Description
- 8.1.5 Abbott Laboratories Recent Development
- 8.2 Bayer Healthcare
- 8.2.1 Bayer Healthcare Corporation Information
- 8.2.2 Bayer Healthcare Overview and Its Total Revenue
- 8.2.3 Bayer Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 Bayer Healthcare Product Description
- 8.2.5 Bayer Healthcare Recent Development
- 8.3 Becton Dickinson
- 8.3.1 Becton Dickinson Corporation Information
- 8.3.2 Becton Dickinson Overview and Its Total Revenue
- 8.3.3 Becton Dickinson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 Becton Dickinson Product Description
- 8.3.5 Becton Dickinson Recent Development
- 8.4 Cepheid
- 8.4.1 Cepheid Corporation Information
- 8.4.2 Cepheid Overview and Its Total Revenue
- 8.4.3 Cepheid Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 Cepheid Product Description
- 8.4.5 Cepheid Recent Development
- 8.5 Dako
- 8.5.1 Dako Corporation Information
- 8.5.2 Dako Overview and Its Total Revenue
- 8.5.3 Dako Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Dako Product Description
- 8.5.5 Dako Recent Development
- 8.6 Danaher Corporation
- 8.6.1 Danaher Corporation Corporation Information
- 8.6.2 Danaher Corporation Overview and Its Total Revenue
- 8.6.3 Danaher Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 Danaher Corporation Product Description
- 8.6.5 Danaher Corporation Recent Development
- 8.7 Gen Probe(Hologic)
- 8.7.1 Gen Probe(Hologic) Corporation Information
- 8.7.2 Gen Probe(Hologic) Overview and Its Total Revenue
- 8.7.3 Gen Probe(Hologic) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 Gen Probe(Hologic) Product Description
- 8.7.5 Gen Probe(Hologic) Recent Development
- 8.8 Roche Diagnostics
- 8.8.1 Roche Diagnostics Corporation Information
- 8.8.2 Roche Diagnostics Overview and Its Total Revenue
- 8.8.3 Roche Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 Roche Diagnostics Product Description
- 8.8.5 Roche Diagnostics Recent Development
- 8.9 Siemens Healthcare
- 8.9.1 Siemens Healthcare Corporation Information
- 8.9.2 Siemens Healthcare Overview and Its Total Revenue
- 8.9.3 Siemens Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 Siemens Healthcare Product Description
- 8.9.5 Siemens Healthcare Recent Development
9 Production Forecasts by Regions
- 9.1 Global Top Oncology Based Molecular Diagnostics Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Oncology Based Molecular Diagnostics Regions Forecast by Production (2021-2026)
- 9.3 Key Oncology Based Molecular Diagnostics Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Oncology Based Molecular Diagnostics Consumption Forecast by Region
- 10.1 Global Oncology Based Molecular Diagnostics Consumption Forecast by Region (2021-2026)
- 10.2 North America Oncology Based Molecular Diagnostics Consumption Forecast by Region (2021-2026)
- 10.3 Europe Oncology Based Molecular Diagnostics Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Oncology Based Molecular Diagnostics Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Oncology Based Molecular Diagnostics Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Oncology Based Molecular Diagnostics Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Oncology Based Molecular Diagnostics Sales Channels
- 11.2.2 Oncology Based Molecular Diagnostics Distributors
- 11.3 Oncology Based Molecular Diagnostics Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Market Opportunities and Drivers
- 12.2 Market Challenges
- 12.3 Market Risks/Restraints
- 12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Oncology Based Molecular Diagnostics Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Oncology Based Molecular Diagnostics. Industry analysis & Market Report on COVID-19 Impact on Global Oncology Based Molecular Diagnostics is a syndicated market report, published as COVID-19 Impact on Global Oncology Based Molecular Diagnostics Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Oncology Based Molecular Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
